Cargando…
Strategies to Improve Chimeric Antigen Receptor Therapies for Neuroblastoma
Chimeric antigen receptors (CARs) are among the curative immunotherapeutic approaches that exploit the antigen specificity and cytotoxicity function of potent immune cells against cancers. Neuroblastomas, the most common extracranial pediatric solid tumors with diverse characteristics, could be a pr...
Autores principales: | Sawaisorn, Piamsiri, Atjanasuppat, Korakot, Anurathapan, Usanarat, Chutipongtanate, Somchai, Hongeng, Suradej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768386/ https://www.ncbi.nlm.nih.gov/pubmed/33322408 http://dx.doi.org/10.3390/vaccines8040753 |
Ejemplares similares
-
Comparison of the efficacy of second and third generation lentiviral vector transduced CAR CD19 T cells for use in the treatment of acute lymphoblastic leukemia both in vitro and in vivo models
por: Sawaisorn, Piamsiri, et al.
Publicado: (2023) -
Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma
por: Vanichapol, Thitinee, et al.
Publicado: (2018) -
Secretory High-Mobility Group Box 1 Protein Affects Regulatory T Cell Differentiation in Neuroblastoma Microenvironment In Vitro
por: Vanichapol, Thitinee, et al.
Publicado: (2018) -
Genomics-Driven Precision Medicine in Pediatric Solid Tumors
por: Suthapot, Praewa, et al.
Publicado: (2023) -
A novel anti-membrane CD30 single-chain variable fragment discovered from the human phage library: A potential targeted immunotherapy
por: Chanpong, Thanida, et al.
Publicado: (2023)